Literature DB >> 31647860

Journal Club-- COPD Exacerbations and Gastroesophageal Reflux Disease: Why Proton Pump Inhibitor Therapy is Not Enough.

Ron Balkissoon1.   

Abstract

Entities:  

Keywords:  chronic obstructive pulmonary disease; copd; exacerbations; gastroesophageal reflux disease; proton pump inhibitor therapy

Year:  2019        PMID： 31647860      PMCID： PMC7006696          DOI： 10.15326/jcopdf.6.4.2019.0162

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN： 2372-952X


× No keyword cloud information.
  19 in total

Review 1.  Aspiration Pneumonia and Related Syndromes.

Authors:  Augustine S Lee; Jay H Ryu
Journal:  Mayo Clin Proc       Date:  2018-05-02       Impact factor: 7.616

Review 2.  Microbiome in reflux disorders and esophageal adenocarcinoma.

Authors:  Liying Yang; Noami Chaudhary; Jonathan Baghdadi; Zhiheng Pei
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

3.  Journal Club - Bronchiectasis/COPD Overlap: Syndrome Versus Treatable Trait?

Authors:  Ron Balkissoon
Journal:  Chronic Obstr Pulm Dis       Date:  2019-04

4.  Susceptibility to exacerbation in chronic obstructive pulmonary disease.

Authors:  John R Hurst; Jørgen Vestbo; Antonio Anzueto; Nicholas Locantore; Hana Müllerova; Ruth Tal-Singer; Bruce Miller; David A Lomas; Alvar Agusti; William Macnee; Peter Calverley; Stephen Rennard; Emiel F M Wouters; Jadwiga A Wedzicha
Journal:  N Engl J Med       Date:  2010-09-16       Impact factor: 91.245

5.  Gastroesophageal reflux-induced bronchoconstriction. Is microaspiration a factor?

Authors:  S M Harding; C A Schan; M R Guzzo; R W Alexander; L A Bradley; J E Richter
Journal:  Chest       Date:  1995-11       Impact factor: 9.410

6.  Inhaled corticosteroid suppression of cathelicidin drives dysbiosis and bacterial infection in chronic obstructive pulmonary disease.

Authors:  Aran Singanayagam; Nicholas Glanville; Leah Cuthbertson; Nathan W Bartlett; Lydia J Finney; Elena Turek; Eteri Bakhsoliani; Maria Adelaide Calderazzo; Maria-Belen Trujillo-Torralbo; Joseph Footitt; Phillip L James; Peter Fenwick; Samuel V Kemp; Thomas B Clarke; Jadwiga A Wedzicha; Michael R Edwards; Miriam Moffatt; William O Cookson; Patrick Mallia; Sebastian L Johnston
Journal:  Sci Transl Med       Date:  2019-08-28       Impact factor: 17.956

7.  Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study.

Authors:  Zhang Wang; Richa Singh; Bruce E Miller; Ruth Tal-Singer; Stephanie Van Horn; Lynn Tomsho; Alexander Mackay; James P Allinson; Adam J Webb; Anthony J Brookes; Leena M George; Bethan Barker; Umme Kolsum; Louise E Donnelly; Kylie Belchamber; Peter J Barnes; Dave Singh; Christopher E Brightling; Gavin C Donaldson; Jadwiga A Wedzicha; James R Brown
Journal:  Thorax       Date:  2017-12-21       Impact factor: 9.139

8.  The human laryngeal microbiome: effects of cigarette smoke and reflux.

Authors:  Marie E Jetté; Kimberly A Dill-McFarland; Alissa S Hanshew; Garret Suen; Susan L Thibeault
Journal:  Sci Rep       Date:  2016-10-24       Impact factor: 4.379

9.  Response of the airways and autonomic nervous system to acid perfusion of the esophagus in patients with asthma: a laboratory study.

Authors:  D Lakmali Amarasiri; Arunasalam Pathmeswaran; H Janaka de Silva; Channa D Ranasinha
Journal:  BMC Pulm Med       Date:  2013-06-02       Impact factor: 3.317

10.  Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial.

Authors:  Donald P Tashkin; Marc Miravitlles; Bartolomé R Celli; Norbert Metzdorf; Achim Mueller; David M G Halpin; Antonio Anzueto
Journal:  Respir Res       Date:  2018-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.